Winston Medical Supply Co., Ltd. (TPEX:6817)

Winston Medical Supply Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	325.77	298.92	299.55	299.14	202.67	162.8
Cash & Short-Term Investments	325.77	298.92	299.55	299.14	202.67	162.8
Cash Growth	-8.60%	-0.21%	0.14%	47.60%	24.49%	11.25%
Accounts Receivable	124.87	142.19	165.33	171.71	186.01	129.24
Other Receivables	0.42	-	0.55	0.07	-	0.17
Receivables	125.28	142.19	165.88	171.78	186.01	129.41
Inventory	153.8	151.17	149.67	115.74	96.22	106.43
Other Current Assets	6.63	8.83	8.92	13.17	13.53	8.4
Total Current Assets	611.47	601.12	624.02	599.82	498.43	407.04
Property, Plant & Equipment	154.79	167.06	169.47	182.73	188.91	217.48
Other Intangible Assets	1.6	1.97	2.37	1.93	1.55	2.31
Long-Term Deferred Tax Assets	5.55	5.9	5.61	6.19	6.71	5.38
Other Long-Term Assets	3.95	4.88	11.21	11.1	5.83	4.21
Total Assets	777.37	780.92	812.67	801.78	701.43	636.41

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	75.44	80.75	107.04	92.5	73.36	69
Accrued Expenses	39.35	55.67	56.07	58.08	43.02	35.74
Current Portion of Long-Term Debt	4.71	4.71	4.71	4.71	4.71	4.71
Current Portion of Leases	3.31	3.24	3.19	3.15	1.35	1.33
Current Income Taxes Payable	8.15	12.66	12.73	24.63	22.99	10.18
Current Unearned Revenue	128.51	134.1	114.72	104.49	104.74	106.57
Other Current Liabilities	103.58	10.97	12.25	11.15	13.3	5.41
Total Current Liabilities	363.05	302.09	310.7	298.69	263.46	232.94
Long-Term Debt	33.65	36	40.71	45.41	50.12	54.83
Long-Term Leases	2.7	4.21	7.45	10.64	5.94	7.29
Pension & Post-Retirement Benefits	1.2	1.42	4.15	8.85	9.96	9.11
Other Long-Term Liabilities	9.62	9.62	10.28	10.28	10.28	6.97
Total Liabilities	410.22	353.35	373.29	373.88	339.76	311.13

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	184.17	184.17	184.17	184.17	184.17	184.17
Additional Paid-In Capital	17.4	17.4	17.4	17.4	17.4	17.4
Retained Earnings	165.58	226	237.81	226.33	160.1	123.71
Total Common Equity	367.15	427.57	439.38	427.9	361.67	325.28
Shareholders' Equity	367.15	427.57	439.38	427.9	361.67	325.28
Total Liabilities & Equity	777.37	780.92	812.67	801.78	701.43	636.41

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	44.36	48.16	56.06	63.92	62.12	68.15
Net Cash (Debt)	281.41	250.76	243.5	235.22	140.56	94.65
Net Cash Growth	-7.52%	2.98%	3.52%	67.35%	48.50%	1252.95%
Net Cash Per Share	15.23	13.57	13.17	12.72	7.60	5.13
Filing Date Shares Outstanding	18.42	18.42	18.42	18.42	18.42	18.42
Total Common Shares Outstanding	18.42	18.42	18.42	18.42	18.42	18.42
Working Capital	248.43	299.02	313.32	301.13	234.98	174.1
Book Value Per Share	19.94	23.22	23.86	23.23	19.64	17.66
Tangible Book Value	365.54	425.6	437.02	425.97	360.12	322.98
Tangible Book Value Per Share	19.85	23.11	23.73	23.13	19.55	17.54
Land	12.75	12.75	12.75	12.75	12.75	12.75
Buildings	153.36	153.36	153.36	153.36	153.13	152.7
Machinery	393.03	398.23	376.79	368.88	366.39	362.28

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 8, 2026

Data Sources Report a data error